Tumour Ablation Devices Market to Grow at a 14.6% CAGR Forecast to 2022

PUNE, INDIA, July 21, 2016 /EINPresswire.com/ -- According to researcher, the Global Tumor Ablation Devices market is estimated at $260.60 million in 2015 and is expected to grow at a CAGR of 14.6% to reach $676.66 million by 2022. Rising incidences of cancers, technological advancements, growing aged population, rising numbers of hospitals and healthcare awareness are the key factors driving the market growth. However, negative effects related to ablation treatment and inadequate performance of the devices is hampering the market.

Complete report details @ https://www.wiseguyreports.com/reports/tumour-ablation-devices-global-market-outlook-2015

Radiofrequency commanded the technology segment in 2015 owing to its prominent application in solid tumor elimination in the body. On the contrary, microwave ablation technology is expected to observe remunerative growth during the predicted period due to advantages offered by this technology. Surgical procedures segment held major share of around 40% in 2015. However, percutaneous procedures are anticipated to observe productive growth over the forecast period owing to increasing demand for minimally invasive procedures offering sooner recovery and improved safety. The Asia-Pacific market is anticipated to grow at a faster pace during the forecast period owing to factors such as huge population with the high incidence of various cancers in the region.

Some of the key players in the global Tumor Ablation Devices market are Alpinion Medical Systems Co., Ltd., Angiodynamics, Baylis Medical, biolitec AG, Biotronic NeuroNetwork, LLC, Boston Scientific Corporation , EDAP TMS S.A, Galil Medical, Inc., HealthTronics , Hironic Co., Ltd., Medtronic Plc. (Covidien), Mermaid Medical A/S, Misonix, Inc., Monteris Medical, Inc, Neuwave Medical Inc. , Perseon, Sonacare Medical, LLC, Spectranetics, St. Jude Medical, Inc., and Symple Surgical Inc.

Request a sample report @ https://www.wiseguyreports.com/sample-request/tumour-ablation-devices-global-market-outlook-2015

Products Covered:
• Thermal
o Radiation Devices
o High intensity focused ultrasound ablation Devices
o Laser ablation Devices
o Microwave ablation Devices
o Radiofrequency ablation Devices
• Non-Thermal
o Cryo ablation Devices
o Hydromechanical Devices
• Other Ablation devices
Treatments Covered:
• Laparoscopic Ablation
• Surgical Ablation
• Percutaneous Ablation
Applications Covered:
• Bone Cancer
• Breast Cancer
• Colorectal Cancer
• Kidney Cancer
• Liver Cancer
• Lung Cancer
• Prostate Cancer
• ENT cancer
• Other Cancers
End User’s Covered:
• Hospitals
• Ambulatory Surgical Centers
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/tumour-ablation-devices-global-market-outlook-2015

Table of Content
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Tumor Ablation Devices Market, By Product
5.1 Introduction
5.2 Thermal
5.2.1 Radiation Devices
5.2.2 High intensity focused ultrasound ablation Devices
5.2.3 Laser ablation Devices
5.2.4 Microwave ablation Devices
5.2.5 Radiofrequency ablation Devices
5.2.5.1 Cardiology
5.2.5.2 Cosmetology
5.2.5.3 Gynecology
5.2.5.4 Hypertension
5.2.5.5 Pain Management
5.2.5.6 Surgical Oncology
5.3 Non-Thermal
5.3.1 Cryo ablation Devices
5.3.2 Hydromechanical Devices
5.4 Other Ablation devices

6 Global Tumor Ablation Devices Market, By Treatment
6.1 Introduction
6.2 Laparoscopic Ablation
6.3 Surgical Ablation
6.4 Percutaneous Ablation

7 Global Tumor Ablation Devices Market, By Application
7.1 Introduction
7.2 Bone Cancer
7.3 Breast Cancer
7.4 Colorectal Cancer
7.5 kidney Cancer
7.6 Liver Cancer
7.7 Lung Cancer
7.8 Prostate Cancer
7.9 ENT cancer
7.10 Other Cancers

8 Global Tumor Ablation Devices Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Ambulatory Surgical Centers

9 Global Tumor Ablation Devices Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Alpinion Medical Systems Co., Ltd.
11.2 Angiodynamics
11.3 Baylis Medical, biolitec AG
11.4 Biotronic NeuroNetwork, LLC
11.5 Boston Scientific Corporation
11.6 EDAP TMS S.A
11.7 Galil Medical, Inc.
11.8 HealthTronics
11.9 Hironic Co., Ltd.
11.10 Medtronic Plc. (Covidien)
11.11 Mermaid Medical A/S
11.12 Misonix, Inc.
11.13 Monteris Medical, Inc
11.14 Neuwave Medical Inc.
11.15 Perseon
11.16 Sonacare Medical, LLC
11.17 Spectranetics
11.18 St. Jude Medical, Inc.
11.19 Symple Surgical Inc.

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=456565

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.